In our study, we analyzed the data, with respect to stratification, based on tumor location and stage, we found that Sox2 had predictive value in cardiac gastric cancers or earlier stage (Stages I and II), but not in non-cardiac gastric cancers or later stage (Stages III and IV). Here, SOX2 is linked to neoplasm.